Evidence map›Paper›PMID 24056945›Full record

ReviewNanoscale2013

Plasmonic nanoprobes: from chemical sensing to medical diagnostics and therapy.

Tuan Vo-Dinh, Andrew M Fales, Guy D Griffin, Christopher G Khoury, Yang Liu, Hoan Ngo, Stephen J Norton, Janna K Register, Hsin-Neng Wang, Hsiangkuo Yuan

Abstract readReview
In one paragraph

Review in Nanoscale, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Gold Nanoparticles in Cancer Theranostics.Frontiers in bioengineering and biotechnology · 2021
    Review
  11. Article
  12. Optical Diagnostic Based on Functionalized Gold Nanoparticles.International journal of molecular sciences · 2019
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tuan Vo-DinhDepartment of Biomedical Engineering, Department of Chemistry, The Fitzpatrick Institute for Photonics, Duke University, Durham, NC 27708, USA. tuan.vodinh@duke.edu.
Andrew M Fales
Guy D Griffin
Christopher G Khoury
Yang Liu
Hoan Ngo
Stephen J Norton
Janna K Register
Hsin-Neng Wang
Hsiangkuo Yuan

Funding

Ultra-High-Throughput Screening (uHTS) Based on Surface*R01EB006201 · NIBIB · DUKE UNIVERSITY · PI VO-DINH, TUAN · 2006 to 2009
$1.9M
NIBIB NIH HHS R01 341 EB006201NIBIB NIH HHS R01 EB006201
6 · The paper itself

Abstract

This article provides an overview of the development and applications of plasmonics-active nanoprobes in our laboratory for chemical sensing, medical diagnostics and therapy. Molecular Sentinel nanoprobes provide a unique tool for DNA/RNA biomarker detection both in a homogeneous solution or on a chip platform for medical diagnostics. The possibility of combining spectral selectivity and high sensitivity of the surface-enhanced Raman scattering (SERS) process with the inherent molecular specificity of nanoprobes provides an important multiplex diagnostic modality. Gold nanostars can provide an excellent multi-modality platform, combining two-photon luminescence with photothermal therapy as well as Raman imaging with photodynamic therapy. Several examples of optical detection using SERS and photonics-based treatments are presented to illustrate the usefulness and potential of the plasmonic nanoprobes for theranostics, which seamlessly combines diagnostics and therapy.

Indexed as

Spectrum Analysis, RamanBiomarkersBiosensing TechniquesDNAGoldHumansNanostructuresNeoplasmsPhotochemotherapyPhotosensitizing AgentsBiomarkersDNAGoldPhotosensitizing Agents

Identifiers

PMID24056945
PMCPMC4355622

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.